Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Molecular Modeling

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00894-009-0565-3PMID 19649663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic profiling of the granular cell layer from rats submitted to the experimental model of temporal lobe epilepsy

  2013cited by this paper
• Docking and MD Simulations of the Interaction of the Tarantula Peptide Psalmotoxin-1 with ASIC1a Channels Using a Homology Model

  2009cited by this paper
• Characterization of a novel mitogen-activated protein kinase kinase 1/2 inhibitor with a unique mechanism of action for cancer therapy.

  2009cited by this paper
• Trypanocidal, leishmanicidal and cytotoxic effects of anthecotulide-type linear sesquiterpene lactones from Anthemis auriculata.

  2009cited by this paper
• Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes α4β2 and α7

  2008cited by this paper
• ERK inhibitors as a potential new therapy for rheumatoid arthritis.

  2008cited by this paper
• Advances in Targeting the Ras/Raf/MEK/Erk Mitogen-Activated Protein Kinase Cascade with MEK Inhibitors for Cancer Therapy

  2008cited by this paper
• Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors.

  2008cited by this paper
• Molecular modeling and simulation studies of ion channel structures, dynamics and mechanisms.

  2008cited by this paper
• Advances in the Development of Cancer Therapeutics Directed against the RAS-Mitogen-Activated Protein Kinase Pathway

  2008cited by this paper
• Localized leishmaniasis of the oral mucosa: A report of three cases

  2007cited by this paper
• Comparative genomic analysis of three Leishmania species that cause diverse human disease

  2007cited by this paper
• Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.

  2006cited by this paper
• Diagnosis & management of leishmania/HIV co-infection.

  2005cited by this paper
• Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex.

  2005cited by this paper
• A robust two-way semi-linear model for normalization of cDNA microarray data

  2005cited by this paper
• Advances in leishmaniasis.

  2005cited by this paper
• Kinetoplastid Biology and Disease BioMed Central

  2005cited by this paper
• Progress in the treatment of a neglected infectious disease: visceral leishmaniasis

  2004cited by this paper
• Inhibitors of Leishmania mexicana CRK3 Cyclin-Dependent Kinase: Chemical Library Screen and Antileishmanial Activity

  2004cited by this paper
• Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.

  2003cited by this paper
• Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs.

  2003cited by this paper
• Indirubin and Meisoindigo in the Treatment of Chronic Myelogenous Leukemia in China

  2002cited by this paper
• Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

  2001cited by this paper
• Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells

  2001cited by this paper
• Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras.

  2000cited by this paper
• Comparative protein structure modeling of genes and genomes.

  2000cited by this paper
• Stereoelectronic properties of antimalarial artemisinin analogues in relation to neurotoxicity.

  1999cited by this paper
• Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

  1999cited by this paper
• Visceral leishmaniasis: a lingual presentation in a patient with HIV infection.

  1998cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• A mitogen‐activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host

  1998cited by this paper
• All-atom empirical potential for molecular modeling and dynamics studies of proteins.

  1998cited by this paper
• Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast.

  1995cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Recognition of errors in three‐dimensional structures of proteins

  1993cited by this paper
• Verification of protein structures: Patterns of nonbonded atomic interactions

  1993cited by this paper
• Cellular and molecular mechanisms of intracellular symbiosis in leishmaniasis.

  1983cited by this paper
• CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

  1983cited by this paper
• Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes

  1977cited by this paper

• An integrative in silico and in vitro study identifies Leishmania donovani MAP kinase12 as a probable virulence factor.

  2023cites this paper
• LM-ANN-based QSAR model for the prediction of pEC50 for a set of potent NNRTI using the mixture of ligand–receptor interaction information and drug-like indexes

  2020cites this paper
• Combination of least absolute shrinkage and selection operator with Bayesian Regularization artificial neural network (LASSO-BR-ANN) for QSAR studies using functional group and molecular docking mixed descriptors

  2020cites this paper
• The Efficiency of Ligand-Receptor Interaction Information Alone as New Descriptors in QSAR Modeling via Random Forest Artificial Neural Network.

  2020cites this paper
• Identification of Leishmania major UDP-Sugar Pyrophosphorylase Inhibitors Using Biosensor-Based Small Molecule Fragment Library Screening

  2019cites this paper
• Studies on the lipid-regulating mechanism of alisol-based compounds on lipoprotein lipase.

  2018cites this paper
• An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.

  2018cites this paper
• Computational elucidation of novel antagonists and binding insights by structural and functional analyses of serine hydroxymethyltransferase and interaction with inhibitors

  2018cites this paper
• Cell wall permeability assisted virtual screening to identify potential direct InhA inhibitors of Mycobacterium tuberculosis and their biological evaluation

  2018cites this paper
• In Silico Screening of Potential Drug with Antileishmanial Activty and Validation of their Activity by in Vitro and in Vivo Studies

  2015cites this paper
• Rational design of new leishmanicidal agents: In silico and In vitro evaluation.

  2015cites this paper
• MAPK1 of Leishmania donovani Modulates Antimony Susceptibility by Downregulating P-Glycoprotein Efflux Pumps

  2015cites this paper
• HOMOLOGY MODELLING OF VP19 AND ITS VALIDATION FOR PREDICTION OF NOVEL BINDING SITES FOR WHITE SPOT SYDROME VIRUS

  2014cites this paper
• Structural insight into the homology modeled human N-acetyl-alpha-neuraminidase 3 (NEU3)

  2014cites this paper
• Extraction of Bioactive Compounds from Millingtonia hortensis for theTreatment of Dapsone Resistance in Leprosy

  2014cites this paper
• Homology modeling, molecular dynamics and atomic level interaction study of snake venom 5′ nucleotidase

  2014cites this paper
• EFFECT OF THE LIGAND IN THE MODELING THE 3 D STRUCTURE OF THE M 3 MUSCARINIC RECEPTOR BAHAREH RASAEIFAR

  2013cites this paper
• Bioinformatics Approach to understand and Exploit the Potential of Lipases

  2013cites this paper
• Interaction between shrimp and white spot syndrome virus through PmRab7-VP28 complex: an insight using simulation and docking studies

  2013cites this paper
• Effect of the ligand in the Modeling the 3d structure of the m3 muscarinic receptor

  2013cites this paper
• Blocking Protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera

  2012cites this paper
• In silico screening of the juvabione category of juvenile hormone analogues with juvenile hormone binding protein of Galleria mellonella – a docking study

  2012cites this paper
• From Tyrian Purple to Kinase Modulators: Naturally Halogenated Indirubins and Synthetic Analogues

  2012cites this paper
• Current Advances in Computational Strategies for Drug Discovery in Leishmaniasis

  2012cites this paper
• Probing the structure of Leishmania major DHFR TS and structure based virtual screening of peptide library for the identification of anti-leishmanial leads

  2012cites this paper
• Protein kinase homology models: recent developments and results.

  2011cites this paper
• Homology modeling and structural analysis of 11β-hydroxysteroid dehydrogenase type 2.

  2011cites this paper
• Parasite Mitogen-Activated Protein Kinases as Drug Discovery Targets to Treat Human Protozoan Pathogens

  2011cites this paper
• Mouse 11β-Hydroxysteroid Dehydrogenase Type 2 for Human Application: Homology Modeling, Structural Analysis and Ligand-Receptor Interaction

  2011cites this paper
• Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques

  2011cites this paper
• Mitogen-activated protein kinase 4 of Leishmania parasite as a therapeutic target.

  2010cites this paper
• Production of recombinant proteins from protozoan parasites.

  2010cites this paper
• Proteomics & Bioinformatics

  year unknowncites this paper